U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C15H21NO.BrH
Molecular Weight 312.245
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of EPTAZOCINE HYDROBROMIDE

SMILES

Br.[H][C@@]12CC3=C(C=C(O)C=C3)[C@@](C)(C1)CCN(C)C2

InChI

InChIKey=KMISFPIWSMSMJD-GPKQSYPGSA-N
InChI=1S/C15H21NO.BrH/c1-15-5-6-16(2)10-11(9-15)7-12-3-4-13(17)8-14(12)15;/h3-4,8,11,17H,5-7,9-10H2,1-2H3;1H/t11-,15-;/m1./s1

HIDE SMILES / InChI

Molecular Formula BrH
Molecular Weight 80.912
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C15H21NO
Molecular Weight 231.3333
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Eptazocine is an opioid analgesic which was introduced in 1987 by Morishita in Japan . It acts as a mixed κappa opioid receptor agonist and mu-opioid receptor antagonist.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
The interaction of eptazocine, a novel analgesic, with opioid receptors.
1985 May
[Preferential action of eptazocine, a novel analgesic, with opioid receptors in isolated guinea pig ileum and mouse vas deferens preparations].
1990 Jan
Patents

Sample Use Guides

In Vivo Use Guide
The induction of anesthesia was started with eptazocine 30 mg iv and thiopental 3-4 mg.kg-1 iv and the trachea was intubated smoothly following succinylcholine 40 mg iv. Then, they were given intravenous droperidol 0.15 mg.kg-1 with inhalation of 70% N2O and 30% O2. Good intraoperative muscle relaxation was obtained by dialferine or pancuronium.
Route of Administration: Intravenous
In Vitro Use Guide
Eptazocine caused a concentration-dependent inhibition against the [3H]-naloxone [( 3H]-NLX) specific binding to rat brain synaptic membrane in the absence of sodium cation and GTP (IC50; 7.83 +/- 1.57 microM). The ratios of IC50 values between the absence to the presence of sodium cation alone or sodium cation and GTP were 3.89 and 4.35, respectively. In addition, eptazocine (10 microM) also produced the significant decrease of [3H]-NLX specific binding in the mouse brain synaptic membrane
Substance Class Chemical
Created
by admin
on Fri Dec 15 17:37:08 GMT 2023
Edited
by admin
on Fri Dec 15 17:37:08 GMT 2023
Record UNII
865626Y4ON
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
EPTAZOCINE HYDROBROMIDE
JAN   MART.   WHO-DD  
Common Name English
EPTAZOCINE HYDROBROMIDE [JAN]
Common Name English
EPTAZOCINE HBR
Common Name English
ST-2121
Code English
1,6-METHANO-1H-4-BENZAZONIN-10-OL, 2,3,4,5,6,7-HEXAHYDRO-1,4-DIMETHYL-, HBR (1:1), (1S,6S)-
Common Name English
(-)-(1S,6S)-2,3,4,5,6,7-HEXAHYDRO-1,4-DIMETHYL-1,6-METHANO-1H-4-BENZAZONIN-10-OL HBR
Common Name English
(-)-(1S,6S)-2,3,4,5,6,7-HEXAHYDRO-1,4-DIMETHYL-1,6-METHANO-1H-4-BENZAZONIN-10-OL HYDROBROMIDE
Systematic Name English
(-)-NIH-9614
Code English
(-)-ST-2121
Code English
MCV-4169
Code English
L-ST-2121
Code English
Eptazocine hydrobromide [WHO-DD]
Common Name English
1,6-METHANO-1H-4-BENZAZONIN-10-OL, 2,3,4,5,6,7-HEXAHYDRO-1,4-DIMETHYL-, HYDROBROMIDE (1:1), (1S,6S)-
Common Name English
EPTAZOCINE HYDROBROMIDE [MART.]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C241
Created by admin on Fri Dec 15 17:37:08 GMT 2023 , Edited by admin on Fri Dec 15 17:37:08 GMT 2023
Code System Code Type Description
SMS_ID
100000087248
Created by admin on Fri Dec 15 17:37:08 GMT 2023 , Edited by admin on Fri Dec 15 17:37:08 GMT 2023
PRIMARY
CAS
72150-17-5
Created by admin on Fri Dec 15 17:37:08 GMT 2023 , Edited by admin on Fri Dec 15 17:37:08 GMT 2023
PRIMARY
ChEMBL
CHEMBL70566
Created by admin on Fri Dec 15 17:37:08 GMT 2023 , Edited by admin on Fri Dec 15 17:37:08 GMT 2023
PRIMARY
FDA UNII
865626Y4ON
Created by admin on Fri Dec 15 17:37:08 GMT 2023 , Edited by admin on Fri Dec 15 17:37:08 GMT 2023
PRIMARY
MESH
C024677
Created by admin on Fri Dec 15 17:37:08 GMT 2023 , Edited by admin on Fri Dec 15 17:37:08 GMT 2023
PRIMARY
NCI_THESAURUS
C96732
Created by admin on Fri Dec 15 17:37:08 GMT 2023 , Edited by admin on Fri Dec 15 17:37:08 GMT 2023
PRIMARY
EVMPD
SUB01924MIG
Created by admin on Fri Dec 15 17:37:08 GMT 2023 , Edited by admin on Fri Dec 15 17:37:08 GMT 2023
PRIMARY
PUBCHEM
11630995
Created by admin on Fri Dec 15 17:37:08 GMT 2023 , Edited by admin on Fri Dec 15 17:37:08 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY